Product Description
The global pelvic organ prolapse repair device market size is estimated to increase over the forecast period to reach $180.1 million by 2027.
The majority of the global pelvic organ prolapse repair device market share was controlled by Boston Scientific, Coloplast, and Caldera Medical. This global market research spans over 70 countries and includes the transvaginal mesh market and the sacrocolpopexy mesh market.
Pelvic organ prolapse (POP) afflicts up to 50% of women who have had children or have undergone menopause. However, the total market for pelvic organ prolapse repair devices has been declining in previous years and is projected to experience a significant decrease over the forecast period outside of COVID-19 related fluctuations.
Market Data Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2027, and Historical Data to 2017
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Procedure Numbers
Throughout this study on the pelvic organ prolapse repair device market, iData Research has performed an analysis on transvaginal mesh repair and sacrocolpopexy mesh repair procedure numbers to increase the accuracy of our market sizing, and provide you with the volume of procedures over a 10-year range and across 70 countries.
Pelvic Organ Prolapse Repair Device Market Insights
The largest market for pelvic organ prolapse repair devices was the North American region. The sacrocpoplexy market is set to experience a slight increase caused by consistent procedure numbers and the major shift away from transvaginal mesh. Unit sales of transvaginal mesh have dropped due to the adverse side effects and increased concern for patient safety. Alongside this, a significant decline is projected over the forecast period, outside of COVID-19 related fluctuations, which is expressed in detail within the report.
Market Share Insights
The global pelvic organ prolapse repair device market was controlled by Boston Scientific, Coloplast, and Caldera Medical.
Boston Scientific held the leading position in the pelvic organ prolapse repair device market with its product portfolio which includes: the Upsylon™ Y-Mesh as a bridging material for sacrocolpopexy treatment of a vaginal vault prolapse, the Colpassist™ vaginal positioning device to place the mesh during the procedure, and others discussed within the report.
Research Regional Coverage
Throughout this report, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:
- North America (the United States and Canada)
- Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
- Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
- Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
- Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
- Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
- Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)